Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wielenga

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The American Journal of Physiology|March 1, 1997
Increased C/EBP in fetal rat small intestine precedes initiation of differentiation marker mRNA synthesisR K Montgomery, E H Rings, J F Thompson, et al.
Leukemia|September 14, 1999
CD44 expression predicts disease outcome in localized large B cell lymphomaP Drillenburg, V J Wielenga, M H Kramer, et al.
Scandinavian Journal of Gastroenterology|March 7, 1998
CD44 splice variants as prognostic markers in colorectal cancerV J Wielenga, R van der Voort, J W Mulder, et al.
Leukemia|December 9, 1998
GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSFH Rozemuller, W Terpstra, E J Rombouts, et al.
Blood|November 14, 1997
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cellsW Terpstra, H Rozemuller, D A Breems, et al.
Leukemia|July 1, 1997
Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomesW Terpstra, P J Leenen, C van den Bos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemiaB Löwenberg, M A Boogaerts, S M Daenen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The American Journal of Physiology|March 1, 1997
Increased C/EBP in fetal rat small intestine precedes initiation of differentiation marker mRNA synthesisR K Montgomery, E H Rings, J F Thompson, et al.
Leukemia|September 14, 1999
CD44 expression predicts disease outcome in localized large B cell lymphomaP Drillenburg, V J Wielenga, M H Kramer, et al.
Scandinavian Journal of Gastroenterology|March 7, 1998
CD44 splice variants as prognostic markers in colorectal cancerV J Wielenga, R van der Voort, J W Mulder, et al.
Leukemia|December 9, 1998
GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSFH Rozemuller, W Terpstra, E J Rombouts, et al.
Blood|November 14, 1997
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cellsW Terpstra, H Rozemuller, D A Breems, et al.
Leukemia|July 1, 1997
Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomesW Terpstra, P J Leenen, C van den Bos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemiaB Löwenberg, M A Boogaerts, S M Daenen, et al.
Pageof 4